Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001 Nov;46(11):2347-52.
doi: 10.1023/a:1012338828418.

Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis

Affiliations

Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis

V Nehra et al. Dig Dis Sci. 2001 Nov.

Abstract

The aim of this study was to determine if a relationship exists between nonalcoholic steatohepatitis (NASH) and serum levels of free fatty acids, choline deficiency, or celiac disease. Forty-seven patients with liver biopsy proven NASH were enrolled. Total serum free fatty acids and anti-endomysial antibodies were determined in all patients, while plasma free and phospholipid-bound choline were determined in 29 patients. Total serum free fatty acid concentration correlated significantly with female gender and serum albumin concentration. Patients with severe fibrosis on liver biopsy had significantly greater serum concentration of free fatty acids than patients without severe fibrosis. Plasma free and phospholipid-bound choline levels were normal and no significant correlation was found between the concentration of plasma free or phospholipid bound choline, and the severity of liver damage. Only one of the 47 patients with NASH had a positive titer for the anti-endomysial antibody. In conclusion, increased serum concentrations of free fatty acids were found in NASH and were associated with development of more severe liver disease. Neither choline deficiency nor celiac sprue by anti-endomysial antibody testing was associated with NASH.

PubMed Disclaimer

References

    1. Am J Gastroenterol. 1999 Sep;94(9):2467-74 - PubMed
    1. Hepatology. 1994 May;19(5):1262-71 - PubMed
    1. Annu Rev Immunol. 1994;12:141-79 - PubMed
    1. Annu Rev Nutr. 1981;1:95-121 - PubMed
    1. Am J Med. 1979 Nov;67(5):811-6 - PubMed

LinkOut - more resources